(Q28324307)

10.2165/00003495-199100425-00007

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199100425-00007

9 November 2022

author name string

J. D. Easton

series ordinal

1

1 reference

Europe PubMed Central

PubMed publication ID

1726215

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726215

Preliminary report of the Stroke Prevention in Atrial Fibrillation Study

9 November 2022

language of work or name

English

0 references

publication date

1991

0 references

published in

Drugs

0 references

volume

42 Suppl 5

0 references

page(s)

39-50

0 references

cites work

1 reference

12 December 2020

The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group

1 reference

12 December 2020

Controlled Trial of Dipyridamole in Cerebral Vascular Disease

1 reference

12 December 2020

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia. Part II: surgical group

1 reference

12 December 2020

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group

1 reference

12 December 2020

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

12 December 2020

The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study

1 reference

12 December 2020

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group

1 reference

12 December 2020

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results

1 reference

12 December 2020

Controlled trial of aspirin in cerebral ischemia

1 reference

12 December 2020

Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

1 reference

12 December 2020

Therapy of ischemic cerebrovascular disease

1 reference

12 December 2020

[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]

1 reference

12 December 2020

Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes

1 reference

12 December 2020

Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management

1 reference

12 December 2020

United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.

1 reference

12 December 2020